GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Total Assets

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Total Assets : $0.70 Mil (As of Jan. 2020)


View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Total Assets?

Cotinga Pharmaceuticals's Total Assets for the quarter that ended in Jan. 2020 was $0.70 Mil.

Total Assets is connected with ROA %. Cotinga Pharmaceuticals's annualized ROA % for the quarter that ended in Jan. 2020 was -231.49%. Total Assets is also linked to Revenue through Asset Turnover. Cotinga Pharmaceuticals's Asset Turnover for the quarter that ended in Jan. 2020 was 0.00.


Cotinga Pharmaceuticals Total Assets Historical Data

The historical data trend for Cotinga Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Total Assets Chart

Cotinga Pharmaceuticals Annual Data
Trend Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.83 5.35 3.00 1.20 0.93

Cotinga Pharmaceuticals Quarterly Data
Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 0.93 0.77 0.72 0.70

Cotinga Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cotinga Pharmaceuticals's Total Assets for the fiscal year that ended in Apr. 2019 is calculated as

Total Assets=Total Equity (A: Apr. 2019 )+Total Liabilities (A: Apr. 2019 )
=-1.793+2.727
=0.93

Cotinga Pharmaceuticals's Total Assets for the quarter that ended in Jan. 2020 is calculated as

Total Assets=Total Equity (Q: Jan. 2020 )+Total Liabilities (Q: Jan. 2020 )
=-2.982+3.677
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cotinga Pharmaceuticals  (OTCPK:COTQF) Total Assets Explanation

Total Assets is connected with ROA %.

Cotinga Pharmaceuticals's annualized ROA % for the quarter that ended in Jan. 2020 is

ROA %=Net Income (Q: Jan. 2020 )/( (Total Assets (Q: Oct. 2019 )+Total Assets (Q: Jan. 2020 ))/ count )
=-1.632/( (0.715+0.695)/ 2 )
=-1.632/0.705
=-231.49 %

Note: The Net Income data used here is four times the quarterly (Jan. 2020) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cotinga Pharmaceuticals's Asset Turnover for the quarter that ended in Jan. 2020 is

Asset Turnover
=Revenue (Q: Jan. 2020 )/( (Total Assets (Q: Oct. 2019 )+Total Assets (Q: Jan. 2020 ))/ count )
=0/( (0.715+0.695)/ 2 )
=0/0.705
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cotinga Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire 05-22-2019